Effect of anti-Mullerian hormone on Sertoli and Leydig cell functions in fetal and immature rats

被引:123
作者
Rouiller-Fabre, V
Carmona, S
Abou Merhi, R
Cate, R
Habert, R
Vigier, B
机构
[1] INRA, Unite Differenciat Cellulaire & Mol, Biol Cellulaire & Mol Lab, F-78352 Jouy En Josas, France
[2] Univ Paris 07, INSERM, INRA, U418, F-75251 Paris, France
[3] Equipe Differenciat Gonade, Lab Physiol Reprod, URA CNRS 1449, F-75251 Paris, France
[4] Biogen Inc, Cambridge, MA 02142 USA
关键词
D O I
10.1210/en.139.3.1213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anti-Mullerian hormone (AMH) is mainly involved in the regression of Mullerian ducts in male fetuses, but it may have other functions linked to gonadal development. The present study examines the effect of AMH on steroidogenesis by Sertoli and Leydig cells in fetal and immature rats during the period where AMH is physiologically produced in the testis. The basal aromatase activity of Sertoli cells in primary culture was strongly stimulated (77-91%) by cAMP. AMH (35 nra) reduced cAMP-stimulated aromatase activity by 49-69% as early as fetal day 16 and until postnatal day 20. This effect was dose dependent and was seen after 48 h in culture. AMH also blocked the Sertoli cell aromatase activity stimulated by FSH, but LH did not stimulate this activity, confirming that the aromatase activity effectively resulted from Sertoli cells and not from contaminating Leydig cells. RT-PCR analysis showed that AMH reduced aromatase activity by decreasing the amount of aromatase messenger RNA. AMH also inhibited the LH-stimulated testosterone production by dispersed fetal Leydig cells in culture in a dose-dependent manner. The inhibitory effect of AMH did not depend on the fetal stage studied (16 or 20 days postconception) and resulted from a drop in the steroidogenic activity of each Leydig cell without affecting the number of 3 beta-hydroxysteroid dehydrogenase-positive cells. These data provide the fir st evidence that AMH, like other members of the transforming growth factor-beta family, has an autocrine/paracrine effect on testicular steroidogenic function during the fetal and prepubertal periods.
引用
收藏
页码:1213 / 1220
页数:8
相关论文
共 55 条
[1]   AROMATIZATION OF ANDROSTENEDIONE BY HUMAN ADIPOSE-TISSUE STROMAL CELLS IN MONOLAYER-CULTURE [J].
ACKERMAN, GE ;
SMITH, ME ;
MENDELSON, CR ;
MACDONALD, PC ;
SIMPSON, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (02) :412-417
[2]  
[Anonymous], SEX INTERNAL SECRETI
[3]   ANTI-MULLERIAN HORMONE AND ANTI-MULLERIAN HORMONE TYPE-II RECEPTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION DURING POSTNATAL TESTIS DEVELOPMENT AND IN THE ADULT TESTIS OF THE RAT [J].
BAARENDS, WM ;
HOOGERBRUGGE, JW ;
POST, M ;
VISSER, JA ;
DEROOIJ, DG ;
PARVINEN, M ;
THEMMEN, APN ;
GROOTEGOED, JA .
ENDOCRINOLOGY, 1995, 136 (12) :5614-5622
[4]  
BAARENDS WM, 1994, DEVELOPMENT, V120, P189
[5]   ABNORMAL SEXUAL DEVELOPMENT IN TRANSGENIC MICE CHRONICALLY EXPRESSING MULLERIAN INHIBITING SUBSTANCE [J].
BEHRINGER, RR ;
CATE, RL ;
FROELICK, GJ ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1990, 345 (6271) :167-170
[6]   MULLERIAN-INHIBITING SUBSTANCE FUNCTION DURING MAMMALIAN SEXUAL DEVELOPMENT [J].
BEHRINGER, RR ;
FINEGOLD, MJ ;
CATE, RL .
CELL, 1994, 79 (03) :415-425
[7]   SOURCE OF ANTI-MULLERIAN HORMONE SYNTHESIZED BY FETAL TESTIS - MULLERIAN-INHIBITING ACTIVITY OF FETAL BOVINE SERTOLI CELLS IN TISSUE-CULTURE [J].
BLANCHARD, MG ;
JOSSO, N .
PEDIATRIC RESEARCH, 1974, 8 (12) :968-971
[8]   ISOLATION OF THE BOVINE AND HUMAN GENES FOR MULLERIAN INHIBITING SUBSTANCE AND EXPRESSION OF THE HUMAN-GENE IN ANIMAL-CELLS [J].
CATE, RL ;
MATTALIANO, RJ ;
HESSION, C ;
TIZARD, R ;
FARBER, NM ;
CHEUNG, A ;
NINFA, EG ;
FREY, AZ ;
GASH, DJ ;
CHOW, EP ;
FISHER, RA ;
BERTONIS, JM ;
TORRES, G ;
WALLNER, BP ;
RAMACHANDRAN, KL ;
RAGIN, RC ;
MANGANARO, TF ;
MACLAUGHLIN, DT ;
DONAHOE, PK .
CELL, 1986, 45 (05) :685-698
[9]   ACTIVIN IS PRODUCED BY RAT SERTOLI CELLS-INVITRO AND CAN ACT AS AN AUTOCRINE REGULATOR OF SERTOLI-CELL FUNCTION [J].
DEWINTER, JP ;
VANDERSTICHELE, HMJ ;
TIMMERMAN, MA ;
BLOK, LJ ;
THEMMEN, APN ;
DEJONG, FH .
ENDOCRINOLOGY, 1993, 132 (03) :975-982
[10]  
DICLEMENTE N, 1994, ENDOCRINE, V2, P553